ISPAD 2024 welcomes the submission of abstracts that make an original contribution to the field. All abstracts submitted will go through a blind, peer-review process carried out by an international review panel. Each abstract will be reviewed by at least two reviewers and the final selection of abstracts will be completed by members of the Abstract Review Committee.


All accepted abstracts will appear from the first day of the conference in their full form in the Session Planner as well as in an abstract eBook shortly after the conference.



  • The deadline for abstract submission is midnight Central European Time (CET) on April 5, 2024. Abstracts will not be accepted after this date.
  • All abstracts must be written in English and in “Sentence case.”
  • All abstracts must be submitted online via the registration form.
  • Abstracts sent by fax, post or email will not be considered. It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as submitted by the author.
  • Please note that it is still possible to edit an abstract, even after clicked “submit”, until the end of the deadline
  • The text should not exceed 2,000 characters including spaces. One table or figure can be inserted, but kindly note that 50 characters per table/figure will be removed from your total abstract count. The text of the abstract should briefly state:
    • Objectives: Indicate the purpose of the study or the hypothesis that was tested.
    • Methods: Include the setting for the study, the subjects, the diagnosis or intervention, and the type of statistical analysis. If references are needed, they should be provided in the text.
    • Results: Present as clearly as possible the outcome of the study and after significance if appropriate
    • Conclusions: Briefly discuss the data and emphasize the significance of the results. All abstracts should disclose primary findings and avoid, whenever possible, avoid statements on what is not in the abstract (on future studies or results), such as “experiments are in progress “or “results will be discussed“.

Rule of Two

Each presenting author may present a maximum of two abstracts at the Conference. There is no limit to the number of abstracts which may be submitted by one author.


Abstract Categories

The abstract categories are the general heading under which abstracts will be submitted and reviewed.

  1. Diabetes and COVID-19
  2. Technology in Diabetes Care
    1. Pumps and CGM
    2. Automated Insulin Delivery, Closed loop
    3. Telemedicine, Digital Health, Decision Support and Artificial Intelligence Applications
  3. Diabetes Pathogenesis, Epidemiology and Etiology
    1. Pathogenesis & Etiology
    2. Epidemiology
  4. Diabetes Care
    1. Outcomes and Care Models
    2. Diabetes at School
    3. Economics and Value Addition/Access to Care
    4. Ethics of Care
    5. General Diabetes Care
  5. Diabetes Therapy and Prevention
    1. New Insulins
    2. Adjunctive Therapies
    3. Other Pharmacologic Agents
    4. Novel Advances and Interventions
  6. Diabetes Education
  7. Diabetes Complications
    1. Acute Complications
    2. Chronic Complications
  8. Childhood Obesity and Type 2 Diabetes
  9. Diabetes in Developing Countries and Migrant Populations
  10. Diabetes-Associated Diseases
  11. Lifestyle, Nutrition and Exercise
  12. Genetics, Immunology and the Environment
  13. Monogenic and other forms of Diabetes
  14. Psychological and Psychosocial Aspects of Diabetes


Notification of Acceptance or Rejection

Notification of acceptance or rejection will be sent to the corresponding author by the end of June 2024. Please note that only the corresponding author (submitter) will receive this email concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

All efforts are made to send the notifications by the planned date. Should there be any delays with the selection process, revised date will be posted here.




It is not allowed to submit an abstract that has been published and/or is likely to be published before the ISPAD Abstract submission deadline (April 5, 2024 23:59 hrs. CET). The Scientific Committee has the right to withdraw an abstract if this data has already been published. However, ISPAD accepts the submission of abstracts that have been presented in recent months at local, national or regional diabetes meetings (e.g. ADA, DDG, EASD).